2. Academic Validation
  3. Design, synthesis and cytotoxic activities of scopoletin-isoxazole and scopoletin-pyrazole hybrids

Design, synthesis and cytotoxic activities of scopoletin-isoxazole and scopoletin-pyrazole hybrids

  • Bioorg Med Chem Lett. 2017 Jan 15;27(2):147-151. doi: 10.1016/j.bmcl.2016.11.089.
Wei Shi 1,  Jinglin Hu 1,  Na Bao 1,  Dongang Li 1,  Li Chen 2,  Jianbo Sun 3
Affiliations

Affiliations

  • 1 Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China.
  • 2 Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China. Electronic address: chenli627@cpu.edu.cn.
  • 3 Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China. Electronic address: sjbcpu@gmail.com.
PMID: 27956344 DOI: 10.1016/j.bmcl.2016.11.089
Abstract

12 novel scopoletin-isoxazole and scopoletin-pyrazole hybrids were designed, synthesized and their chemical structures were confirmed by HR-MS, IR, 1H NMR and 13C NMR spectra. The Anticancer activities of the newly synthesized compounds were evaluated in vitro against three human Cancer cell lines including HCT-116, Hun7 and SW620 by MTT assay. The screening results showed that six compounds (9a, 9c, 9d, 12a, 18b and 18d) exhibited potent cytotoxic activities with IC50 values below 20μM. Besides, we have further evaluated the growth inhibitory activities of six compounds against the human normal tissue cell lines HFL-1. Especially, compound 9d displayed significant anti-proliferative activity with IC50 values ranging from 8.76μM to 9.83μM and weak cytotoxicity with IC50 value of 90.9μM on normal cells HFL-1, which suggested that isoxazole-based hybrids of scopoletin were an effective chemical modification to improve the Anticancer activity of scopoletin.

Keywords

Cytotoxic activity; Isoxazole; Pyrazole; Scopoletin.

Figures